Geremy Thomas, founder and Chief Executive Officer of Sativa, said: “Cenkos is a top-ranking financial adviser and broker and has demonstrated its knowledge of the medicinal cannabis and CBD wellness industry by recently publishing a world-class and highly detailed industry note.
“Cenkos’ appointment is in line with Sativa’s progression from, in only 15 months, being the UK’s first listed medicinal cannabis investment vehicle to its transition to a fully operational seed-to-consumer trading business.
“The UK medicinal cannabis industry has significant growth opportunities and we look forward to working with Cenkos on the Company’s next phase of development, which will include engaging with major institutional investors who are now showing an interest for medicinal cannabis and CBD wellness equities.”
Sativa Group PLC (NEX:SATI), the UK’s leading quoted medicinal cannabis and wellness cannabidiol (CBD) group, has appointed Cenkos Securities plc as its Corporate Adviser and broker with immediate effect.
The Board of Sativa wish to thank Peterhouse for its support at the Company’s listing on the NEX Exchange in March 2018 and through its first 15 months of trading.
The Directors of the Company accept responsibility for the contents of this announcement.
